Prevalence of obstructive airway disease in pulmonary function tests of patients visiting respiratory medicine out patient department
DOI:
https://doi.org/10.18203/2320-6012.ijrms20230577Keywords:
Obstructive airway disease, Prevalence, PFT, Respiratory medicine, COPDAbstract
Background: The recognition of obstructive airway disease as a public health problem, however, has failed to keep pace with its increasing impact on health-care resources. This study is conducted to evaluate the prevalence of obstructive airway disease in pulmonary function tests (PFT) of patients visiting respiratory medicine out patient department (OPD).
Methods: This is a retrospective study of patients from October 2020 to September 2022 (2 years), on 80 subjects reporting to respiratory medicine OPD, MGM medical college, Aurangabad. Data collected from 80 subjects who were diagnosed with obstructive airway disease in PFT.
Results: The study population had a COPD prevalence of 16 (19.7%). GOLD criterion revealed that 54.2% (9/16) of COPD patients had mild COPD. This research showed no evidence of very severe COPD. In terms of gender distribution, 8 (16.6%) of 46 males and 7 (19.5%) of 34 women had COPD. However, there was no statistically significant (p=0.167) difference in COPD prevalence between sexes. Furthermore, univariable analysis revealed no significant differences in marital status (p=0.836), co-morbidities (p=0.541), family size (p=0.535), educational status (p=0.827), employment status (p=0.643), and medical visits (p=0.366) between persons with and without COPD.
Conclusions: According to the findings of this research, the variables that increase a person's likelihood of developing COPD are as follows: advancing age, prolonged exposure to smoke from biomass burning, tobacco use, and inadequate ventilation in the kitchen.
References
National Heart. Lung, and Blood Institute. NHLBI morbidity and mortality chartbook, 2000. Available at http://www. nhlbi.nih.gov/resources/docs/cht-book.htm. Accessed on May 6, 2003.
Murray CJL, Lopez AD. Evidence-based health policy: lessons from the global burden of disease study. Science. 1996;274:740-3.
Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest. 2000;117:1S-4.
Voelkel NF. Raising awareness of COPD in primary care. Chest. 2000;117:372S-5.
Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532-55.
Barreiro TJ, Perillo MD. An Approach to Interpreting Spirometry. Am Fam Physician. 2004;69(5):1107-14.
Van Gemert F, Kirenga B, Chavannes N, Kamya M, Luzige S, Musinguzi P et al. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (fresh air Uganda): a prospective cross-sectional observational study. Lancet Glob Health. 2015;3:e44-51.
Magitta NF, Walker RW, Apte KK, Shimwela MD, Mwaiselage JD, Sanga AA et al. Prevalence, risk factors and clinical correlates of COPD in a rural setting in Tanzania. Eur Respir J. 2018;51:1700182.
Finney LJ, Feary JR, Leonardi-Bee J, Gordon SB, Mortimer K. Chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review. Int J Tuber Lung Dis. 2013;17:583-9.
Adeloye D, Basquill C, Papana A, Chan KY, Rudan I, Campbell H. An estimate of the prevalence of COPD in Africa: a systematic analysis. COPD. 2015;12(1):71-81.
Menezes AM, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366:1875-81.
Jaganath D, Miranda JJ, Gilman RH, Wise RA, Diette GB, Miele CH et al. Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru. Respir Res. 2015;16:40.
Bird Y, Moraros J, Mahmood R, Esmaeelzadeh S, Soe NM. Prevalence and associated factors of COPD among aboriginal peoples in Canada: a cross-sectional study. Int J COPD. 2017;12:1915-22.
Badway MS, Hamed AF, Yousef FM. Prevalence of chronic obstructive pulmonary disease (COPD) in Qena governorate. Egypt J Chest Dis Tuberc. 2016;65:29-34.
Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and nutrition examination survey. Respirology. 2011;16(4):659-65.
Bárbara C, Rodrigues F, Dias H, Cardoso J, Almeida J, Matos MJ, et al. Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study. Rev Port Pneumol. 2013;19(3):96-105.
Vanfleteren LE, Franssen FM, Wesseling G, Wouters EF. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands. Respir Med. 2012;106(6):871-4.
Minas M, Hatzoglou C, Karetsi E, Papaioannou AI, Tanou K, Tsaroucha R et al. COPD prevalence and the differences between newly and previously diagnosed COPD patients in a spirometry program. Prim Care Respir J. 2010;19(4):363-70.
Chuchalin AG, Khaltaev N, Antonov NS, Galkin DV, Manakov LG, Antonini P et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int J Chron Obstruct Pulmon Dis. 2014;9:963-74.
Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532-55.
Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765.
Sutradhar I, Gupta RD, Hasan M, Wazib A, Sarker M. Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in Bangladesh: A Systematic Review. Cureus. 2019;11(1):e3970.
Alam DS, Chowdhury MA, Siddiquee AT, Ahmed S, Clemens JD. Prevalence and determinants of chronic obstructive pulmonary disease (COPD) in Bangladesh. COPD: J Chron Obstruct Pulmon Dis. 2015;12(6):658-67.
Nugmanova D, Feshchenko Y, Iashyna L, Gyrina O, Malynovska K, Mammadbayov E et al. The prevalence, burden and risk factors associated with chronic obstructive pulmonary disease in commonwealth of independent states (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study. BMC Pulm Med. 2018;18:26.
Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009;18(114):213-21.
Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:733-43.
Ramírez-Venegas A, Velázquez-Uncal M, Pérez-Hernández R, Guzmán-Bouilloud NE, Falfán-Valencia R, Mayar-Maya ME et al. Prevalence of COPD and respiratory symptoms associated with biomass smoke exposure in a suburban area. Int J COPD. 2018;13:1727-34.
Martin WJ, Glass RI, Balbus JM, Collins FS. A major environmental cause of death. Science. 2011;334:180-1.
Capistrano S, van Reyk D, Chen H, Oliver B. Evidence of biomass smoke exposure as a causative factor for the development of COPD. Toxics. 2017;5:36.
Gordon SB, Bruce NG, Grigg J, Hibberd PL, Kurmi OP, Lam KB et al. Respiratory risks from household air pollution in low- and middle-income countries. Lancet Respir Med. 2014;2:823-60.
Salvi S, Barnes PJ. Is exposure to biomass smoke the biggest risk factor for COPD globally? Chest. 2010;138:3-6.
Capistrano S, van Reyk D, Chen H, Oliver B. Evidence of biomass smoke exposure as a causative factor for the development of COPD. Toxics. 2017;5:36.
Kiraz K, Kart L, Emir R, Oymak S, Gulmez I, Unalacak M et al. Chronic pulmonary disease in rural women exposed to boimass fumes. Clin Invest Med. 2003;26:243-8.
Bruce N, Perez-Padilla R, Albalak R. Indoor air pollution in developing countries: a major environmental and public health challenge. Bull World Health Organ. 2000;78(9):1078-92.
Andreeva E, Pokhaznikova M, Lebedev A, Moiseeva I, Kutznetsova O, Degryse JM. The prevalence of chronic obstructive pulmonary disease by the global lung initiative equations in North-Western Russia. Respiration. 2016;91(1):4355.
Daldoul H, Denguezli M, Jithoo A, Gnatiuc L, Buist S, Burney P et al. Prevalence of COPD and tobacco smoking in Tunisia − results from the BOLD study. Int J Environ Res Public Heal. 2013;10:7257-71.
